U.S. house of representatives targets China with new legislation
The newly passed bills are criticised as a continuation of the "China threat" narrative, which some argue reflects outdated Cold War-era thinking and ideological biases.
Stay updated with the latest news and articles about WuXi AppTec.
The newly passed bills are criticised as a continuation of the "China threat" narrative, which some argue reflects outdated Cold War-era thinking and ideological biases.
The legislation aims at restricting federal agencies from entering into contracts with several prominent Chinese biotech companies, including BGI Group, MGI, Complete Genomics, and WuXi AppTec, along with their subsidiaries.